Angiotensin III (human, mouse): Structure, Mechanism, and Role in RAAS Research

Executive Summary: Angiotensin III (human, mouse) (CAS: 13602-53-4) is a biologically active hexapeptide and a critical component of the renin-angiotensin-aldosterone system (RAAS) (Oliveira et al., 2025). It is generated from angiotensin II via N-terminal cleavage by angiotensinase, mediates approximately 40% of the pressor activity of angiotensin II, and retains full aldosterone-stimulating capability (APExBIO). Angiotensin III interacts with AT1 and AT2 receptors, showing relative specificity for AT2, and is highly soluble in water, ethanol, and DMSO under standard laboratory conditions. Its validated effects on aldosterone secretion and renin suppression make it a gold-standard tool for cardiovascular, neuroendocrine, and RAAS signaling research (internal evidence).

Biological Rationale

Angiotensin III (sequence: Arg-Val-Tyr-Ile-His-Pro-Phe) is generated by N-terminal cleavage of angiotensin II in erythrocytes and tissues through angiotensinase activity (Oliveira et al., 2025). As part of the RAAS, it regulates blood pressure, fluid balance, and electrolyte homeostasis. In human and rodent systems, angiotensin III mediates significant pressor and dipsogenic responses, paralleling but distinct from angiotensin II effects. Notably, angiotensin III retains full aldosterone-stimulating properties, which are essential for sodium and water retention (APExBIO). Its role is pivotal in cardiovascular and neuroendocrine system modeling, providing a more nuanced understanding of receptor subtype contributions.

Mechanism of Action of Angiotensin III (human, mouse)

Angiotensin III is a potent agonist of both AT1 and AT2 receptors. It shows a higher relative selectivity for the AT2 receptor compared to angiotensin II. Upon receptor engagement, angiotensin III induces aldosterone secretion from the adrenal cortex and suppresses renin release, thereby modulating blood pressure via feedback on the RAAS (Oliveira et al., 2025). Exogenous application in rodent models produces robust pressor and dipsogenic responses, making it suitable for dissecting receptor-driven pathways in vivo and in vitro. The peptide's structure (molecular weight: 931.09 Da; formula: C46H66N12O9) and high solubility (≥23.2 mg/mL in water, ≥43.8 mg/mL in ethanol, ≥93.1 mg/mL in DMSO at 20–25°C) enable flexible experimental applications (APExBIO).

Evidence & Benchmarks

• Angiotensin III mediates approximately 40% of the pressor activity of angiotensin II while retaining full aldosterone-stimulating capacity (APExBIO).
• It exhibits higher relative specificity for the AT2 receptor versus angiotensin II, allowing differentiation of receptor subtype contributions in RAAS research (Oliveira et al., 2025).
• Exogenous angiotensin III reliably induces aldosterone secretion and suppresses renin release in animal and cell models (DOI).
• In rodent brain models, angiotensin III administration triggers pressor and dipsogenic responses similar to angiotensin II, validating its use in neuroendocrine signaling research (Internal Report).
• High-purity Angiotensin III (human, mouse) from APExBIO is benchmarked for solubility and stability, supporting reproducible results in both in vitro and in vivo studies (internal scenario guide).
• Recent evidence links N-terminally truncated angiotensin peptides, including angiotensin III, to enhanced viral receptor interactions, underscoring their potential pathophysiological significance (Oliveira et al., 2025).

Applications, Limits & Misconceptions

Angiotensin III (human, mouse) is primarily used for:

• Discriminating AT1 vs. AT2 receptor signaling in cardiovascular disease and hypertension models.
• Inducing and quantifying aldosterone secretion in adrenal or cell-based assays.
• Modeling neuroendocrine responses, such as vasopressin release or thirst.
• Investigating the feedback suppression of renin in RAAS pathway studies.
• As a research-grade tool in infectious disease models exploring RAAS components and viral receptor interactions.

This article extends findings from Angiotensin III: Versatile RAAS Peptide for Cardiovascular Research by offering atomic-level evidence, and clarifies application boundaries addressed in Atomic Evidence for RAAS, Pressor & Aldosterone Activity. For actionable workflow integration and assay guidance, see Advancing Cell Assay Reliability; this article uniquely details mechanism and receptor specificity.

Common Pitfalls or Misconceptions

• Angiotensin III is not a direct substitute for angiotensin II in all receptor-activation experiments; it shows distinct receptor selectivity and efficacy.
• Long-term storage in solution at room temperature leads to peptide degradation—only desiccated -20°C storage is recommended (APExBIO).
• Solubility may be buffer-dependent; always confirm compatibility with target assay conditions.
• The peptide does not activate non-RAAS pathways and should not be used as a general pressor agent outside validated models.
• The enhancing effects on viral receptor (e.g., AXL) binding are observed in vitro and may not directly translate to all in vivo settings (Oliveira et al., 2025).

Workflow Integration & Parameters

APExBIO's Angiotensin III (human, mouse) (SKU: A1043) is a solid peptide suitable for direct dissolution in water, ethanol, or DMSO. Recommended working concentrations vary by model: typical in vitro applications use 1–100 μM, while in vivo rodent studies may employ 10–1000 ng/kg body weight. For best results, freshly prepare solutions and avoid repeated freeze-thaw cycles. Store lyophilized powder desiccated at -20°C; do not store solutions longer than 48 hours at 4°C. Confirm peptide identity and purity by HPLC and mass spectrometry prior to critical assays (internal scenario guide). For cell-based aldosterone or renin assays, validate receptor subtype expression and titrate peptide dose accordingly.

Conclusion & Outlook

Angiotensin III (human, mouse) is an essential research peptide for dissecting RAAS functions, AT1/AT2 signaling, and aldosterone regulation. Its validated stability, solubility, and biological specificity make it a reference standard for cardiovascular and neuroendocrine studies. Ongoing research, including interactions with viral receptors, underscores its emerging translational relevance. For detailed applications and ordering, see the Angiotensin III (human, mouse) product page.